Washington, D.C., United States, February 15th, 2026, FinanceWire

Geneva, Switzerland, February 15th, 2026, FinanceWire

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity ECG platform designed […]

Innovation-focused names are setting the tone this morning, with capital flows clustering around companies showing clear execution milestones, commercial inflection points, and technical breakouts.